The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Uric acid and chronic kidney disease: which is chasing which?
Open accessAbstract
Serum uric acid is commonly elevated in subjects with chronic kidney disease (CKD), but was historically viewed as an issue of limited interest. Recently, uric acid has been resurrected as a potential contributory risk factor in the development and progression of CKD. Most studies documented that an elevated serum uric acid level independently predicts the development of CKD. Raising the uric acid level in rats can induce glomerular hypertension and renal disease as noted by the development of arteriolosclerosis, glomerular injury and tubulointerstitial fibrosis. Pilot studies suggest that lowering plasma uric acid concentrations may slow the progression of renal disease in subjects with CKD. While further clinical trials are necessary, uric acid is emerging as a potentially modifiable risk factor for CKD. Gout was considered a cause of CKD in the mid-nineteenth century, and, prior to the availability of therapies to lower the uric acid level, the development of end-stage renal disease was common in gouty patients. In their large series of gouty subjects Talbott and Terplan found that nearly 100% had variable degrees of CKD at autopsy (arteriolosclerosis, glomerulosclerosis and interstitial fibrosis). Additional studies showed that during life impaired renal function occurred in half of these subjects. As many of these subjects had urate crystals in their tubules and interstitium, especially in the outer renal medulla, the disease became known as gouty nephropathy. The identity of this condition fell in question as the presence of these crystals may occur in subjects without renal disease; furthermore, the focal location of the crystals could not explain the diffuse renal scarring present. In addition, many subjects with gout also had coexistent conditions such as hypertension and vascular disease, leading some experts to suggest that the renal injury in gout was secondary to these latter conditions rather than to uric acid per se. Indeed, gout was removed from the textbooks as a cause of CKD, and the common association of hyperuricemia with CKD was solely attributed to the retention of serum uric acid that is known to occur as the glomerular filtration rate falls. Renewed interest in uric acid as a cause of CKD occurred when it was realized that invalid assumptions had been made in the arguments to dismiss uric acid as a risk factor for CKD. The greatest assumption was that the mechanism by which uric acid would cause kidney disease would be via the precipitation as crystals in the kidney, similar to the way it causes gout. However, when laboratory animals with CKD were made hyperuricemic, the renal disease progressed rapidly despite an absence of crystals in the kidney. Since this seminal study, there has been a renewed interest in the potential role uric acid may have in both acute and CKD. We briefly review some of the major advances that have occurred in this field in the last 15 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Uric Acid and Cardiovascular Risk
Feig, D. I., Kang, D.-H., & Johnson, R. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800885 · Cited by 2,440
Self-citationSugar-Sweetened Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes
Malik, V. S., Popkin, B. M., Bray, G. A., Després, J.-P., Willett, W. C., & Hu, F. B. (2010) · Diabetes Care · doi:10.2337/dc10-1079 · Cited by 2,116
A Role for Uric Acid in the Progression of Renal Disease
Kang, D.-H., Nakagawa, T., Feng, L., Watanabe, S., Han, L., Mazzali, M., Truong, L., Harris, R., & Johnson, R. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000034910.58454.fd · Cited by 1,304
Self-citationElevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism
Mazzali, M., Hughes, J., Kim, Y.-G., Jefferson, J. A., Kang, D.-H., Gordon, K. L., Lan, H. Y., Kivlighn, S., & Johnson, R. J. (2001) · Hypertension · doi:10.1161/hy1101.092839 · Cited by 1,300
Self-citationPurine-Rich Foods, Dairy and Protein Intake, and the Risk of Gout in Men
Choi, H. K., Atkinson, K., Karlson, E. W., Willett, W., & Curhan, G. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035700 · Cited by 1,178
A causal role for uric acid in fructose-induced metabolic syndrome
Nakagawa, T., Hu, H., Zharikov, S., Tuttle, K. R., Short, R. A., Glushakova, O., Ouyang, X., Feig, D. I., Block, E. R., Herrera-Acosta, J., et al. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00140.2005 · Cited by 1,104
Self-citationKang, D.-H., Park, S.-K., Lee, I.-K., & Johnson, R. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050572 · Cited by 882
Self-citationStrauss, M. B., & Welt, L. G. (1963) · Little, Brown eBooks · Cited by 852
Siu, Y.-P., Leung, K.-T., Tong, M. K.-H., & Kwan, T.-H. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.006 · Cited by 834
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Goicoechea, M., de Vinuesa, S. G., Verdalles, U., Ruiz-Caro, C., Ampuero, J., Rincón, A., Arroyo, D., & Luño, J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01580210 · Cited by 834
Mazzali, M., Kanellis, J., Han, L., Feng, L., Xia, Y.-Y., Chen, Q., Kang, D.-H., Gordon, K. L., Watanabe, S., Nakagawa, T., et al. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00283.2001 · Cited by 826
Self-citationCorry, D. B., Eslami, P., Yamamoto, K., Nyby, M. D., Makino, H., & Tuck, M. L. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f240bf · Cited by 751
Multiple loci associated with indices of renal function and chronic kidney disease
Köttgen, A., Glazer, N. L., Dehghan, A., Hwang, S.-J., Katz, R., Li, M., Yang, Q., Gudnason, V., Launer, L. J., Harris, T. B., et al. (2009) · Nature Genetics · doi:10.1038/ng.377 · Cited by 647
Schumacher, H. R., Becker, M. A., Wortmann, R. L., MacDonald, P. A., Hunt, B., Streit, J., Lademacher, C., & Joseph‐Ridge, N. (2008) · Arthritis Care & Research · doi:10.1002/art.24209 · Cited by 638 · cited 1×
“For example, one randomized doubleblind trial [80] comprised 1072 patients with gout, serum uric acid >8 mg/dL and either normal serum creatinine or serum creatinine 1.”
BackgroundYu, M.-A., Sánchez-Lozada, L. G., Johnson, R. J., & Kang, D.-H. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328337da1d · Cited by 626 · cited 1×
“For one thing, uric acid stimulates the production of angiotensin II in vascular cells and also increases renin expression in laboratory animals [10, 19, 71].”
BackgroundSelf-citationSanchez-Lozada, L. G., Tapia, E., Santamaria, J., Avila-Casado, C., Soto, V., Nepomuceno, T., Rodriguez-Iturbe, B., Johnson, R. J., & Herrera-Acosta, J. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00074.x · Cited by 556
Self-citationHyperuricemia in Childhood Primary Hypertension
Feig, D. I., & Johnson, R. J. (2003) · Hypertension · doi:10.1161/01.hyp.0000085858.66548.59 · Cited by 535
Self-citationBecker, M. A., Schumacher, H. R., Espinoza, L. R., Wells, A. F., MacDonald, P., Lloyd, E., & Lademacher, C. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2978 · Cited by 529
Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes?
Johnson, R. J., Perez-Pozo, S. E., Sautin, Y. Y., Manitius, J., Sanchez-Lozada, L. G., Feig, D. I., Shafiu, M., Segal, M., Glassock, R. J., Shimada, M., et al. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0033 · Cited by 505
Self-citationEffect of insulin on uric acid excretion in humans
Quinones Galvan, A., Natali, A., Baldi, S., Frascerra, S., Sanna, G., Ciociaro, D., & Ferrannini, E. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.1.e1 · Cited by 451
Uric Acid and Long-term Outcomes in CKD
Madero, M., Sarnak, M. J., Wang, X., Greene, T., Beck, G. J., Kusek, J. W., Collins, A. J., Levey, A. S., & Menon, V. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.12.021 · Cited by 436
Sugar-Sweetened Beverages, Serum Uric Acid, and Blood Pressure in Adolescents
Nguyen, S., Choi, H. K., Lustig, R. H., & Hsu, C.-Y. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.01.015 · Cited by 367
Sánchez-Lozada, L. G., Lanaspa, M. A., Cristóbal-García, M., García-Arroyo, F., Soto, V., Cruz-Robles, D., Nakagawa, T., Yu, M. A., Kang, D.-H., & Johnson, R. J. (2012) · Nephron Experimental Nephrology · doi:10.1159/000345509 · Cited by 340
Self-citationRole of oxidative stress in the renal abnormalities induced by experimental hyperuricemia
Sánchez-Lozada, L. G., Soto, V., Tapia, E., Avila-Casado, C., Sautin, Y. Y., Nakagawa, T., Franco, M., Rodríguez-Iturbe, B., & Johnson, R. J. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00104.2008 · Cited by 312
Self-citationZoppini, G., Targher, G., Chonchol, M., Ortalda, V., Abaterusso, C., Pichiri, I., Negri, C., & Bonora, E. (2012) · Diabetes Care · doi:10.2337/dc11-1346 · Cited by 274
Hyperuricemia Causes Glomerular Hypertrophy in the Rat
Nakagawa, T., Mazzali, M., Kang, D.-H., Kanellis, J., Watanabe, S., Sanchez-Lozada, L. G., Rodriguez-Iturbe, B., Herrera-Acosta, J., & Johnson, R. J. (2003) · American Journal of Nephrology · doi:10.1159/000066303 · Cited by 269
Self-citationJohnson, R. J., Kivlighn, S. D., Kim, Y.-G., Suga, S., & Fogo, A. B. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70295-7 · Cited by 267
Self-citationRyu, E.-S., Kim, M. J., Shin, H.-S., Jang, Y.-H., Choi, H. S., Jo, I., Johnson, R. J., & Kang, D.-H. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00560.2012 · Cited by 259
Self-citationHypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy
Syrjänen, J., Mustonen, J., & Pasternack, A. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.1.34 · Cited by 257
TALBOTT, J. H., & TERPLAN, K. L. (1960) · Medicine · doi:10.1097/00005792-196012000-00001 · Cited by 252
J-Shaped Mortality Relationship for Uric Acid in CKD
Suliman, M. E., Johnson, R. J., García-López, E., Qureshi, A. R., Molinaei, H., Carrero, J. J., Heimbürger, O., Bárány, P., Axelsson, J., Lindholm, B., et al. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.08.019 · Cited by 243
Self-citationHypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension
Feig, D. I., Nakagawa, T., Ananth Karumanchi, S., Oliver, W. J., Kang, D.-H., Finch, J., & Johnson, R. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00729.x · Cited by 240
Self-citationUric Acid Induces Renal Inflammation via Activating Tubular NF-κB Signaling Pathway
Zhou, Y., Fang, L., Jiang, L., Wen, P., Cao, H., He, W., Dai, C., & Yang, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039738 · Cited by 219
Ficociello, L. H., Rosolowsky, E. T., Niewczas, M. A., Maselli, N. J., Weinberg, J. M., Aschengrau, A., Eckfeldt, J. H., Stanton, R. C., Galecki, A. T., Doria, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0227 · Cited by 218
Serum Uric Acid as a Predictor for Development of Diabetic Nephropathy in Type 1 Diabetes
Hovind, P., Rossing, P., Tarnow, L., Johnson, R. J., & Parving, H.-H. (2009) · Diabetes · doi:10.2337/db09-0014 · Cited by 215
Self-citationUric acid and the state of the intrarenal renin-angiotensin system in humans
Perlstein, T. S., Gumieniak, O., Hopkins, P. N., Murphey, L. J., Brown, N. J., Williams, G. H., Hollenberg, N. K., & Fisher, N. D. L. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00909.x · Cited by 214
Sánchez-Lozada, L. G., Tapia, E., Bautista-García, P., Soto, V., Ávila-Casado, C., Vega-Campos, I. P., Nakagawa, T., Zhao, L., Franco, M., & Johnson, R. J. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00454.2007 · Cited by 187
Self-citationMiao, Y., Ottenbros, S. A., Laverman, G. D., Brenner, B. M., Cooper, M. E., Parving, H.-H., Grobbee, D. E., Shahinfar, S., de Zeeuw, D., & Lambers Heerspink, H. J. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.171488 · Cited by 182
Talaat, K. M., & El-Sheikh, A. R. (2007) · American Journal of Nephrology · doi:10.1159/000105142 · Cited by 178
Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice
Kosugi, T., Nakayama, T., Heinig, M., Zhang, L., Yuzawa, Y., Sanchez-Lozada, L. G., Roncal, C., Johnson, R. J., & Nakagawa, T. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00092.2009 · Cited by 172
Self-citationSturm, G., Kollerits, B., Neyer, U., Ritz, E., & Kronenberg, F. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.01.006 · Cited by 170
Self-citationJalal, D. I., Rivard, C. J., Johnson, R. J., Maahs, D. M., McFann, K., Rewers, M., & Snell-Bergeon, J. K. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp740 · Cited by 170
Self-citationSerum Uric Acid and Renal Prognosis in Patients with IgA Nephropathy
Ohno, I., Hosoya, T., Gomi, H., Ichida, K., Okabe, H., & Hikita, M. (2001) · Nephron · doi:10.1159/000045939 · Cited by 169
Franco, M. D. C., Christofalo, D. M. J., Sawaya, A. L., Ajzen, S., & Sesso, R. (2006) · Hypertension · doi:10.1161/01.hyp.0000223446.49596.3a · Cited by 167
Shi, Y., Chen, W., Jalal, D., Li, Z., Chen, W., Mao, H., Yang, Q., Johnson, R. J., & Yu, X. (2012) · Kidney and Blood Pressure Research · doi:10.1159/000331453 · Cited by 166
Self-citationHypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes
Bo, S., Cavallo‐Perin, P., Gentile, L., Repetti, E., & Pagano, G. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00812.x · Cited by 162
Kohagura, K., Kochi, M., Miyagi, T., Kinjyo, T., Maehara, Y., Nagahama, K., Sakima, A., Iseki, K., & Ohya, Y. (2012) · Hypertension Research · doi:10.1038/hr.2012.135 · Cited by 153
Jung, J., Song, W., Kim, Y.-S., Joo, K. W., Lee, K., Kim, S.-H., Park, H., Chang, Y., Cho, S., Min, K. ‐., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr060 · Cited by 142
Effects of acute and chronic l -arginine treatment in experimental hyperuricemia
Sánchez‐Lozada, L. G., Tapia, E., López-Molina, R., Nepomuceno‐Mejía, T., Soto, V., Ávila-Casado, C., Nakagawa, T., Johnson, R. J., Herrera-Acosta, J., & Franco, M. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00164.2006 · Cited by 139
Self-citationA study of the natural history of diabetic kidney disease (DKD)
Altemtam, N., Russell, J., & Nahas, M. E. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr561 · Cited by 130
Effect of allopurinol in decreasing proteinuria in type 2 diabetic patients.
Momeni, A., Shahidi, S., Seirafian, S., Taheri, S., & Kheiri, S. (2010) · Iranian Journal of Kidney Diseases · Cited by 130
Shoham, D. A., Durazo-Arvizú, R., Kramer, H., Luke, A., Vupputuri, S. X., Kshirsagar, A. V., & Cooper, R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003431 · Cited by 119
Ito, H., Abe, M., Mifune, M., Oshikiri, K., Antoku, S., Takeuchi, Y., & Togane, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027817 · Cited by 106
Serum Uric Acid and the Renin‐Angiotensin System in Hypertension
Saito, I., Saruta, T., Kondo, K., Nakamura, R., Oguro, T., Yamagami, K., Ozawa, Y., & Kato, E. (1978) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1978.tb02396.x · Cited by 95
Gonzalez, H. E., Eugenín, E. A., Garcés, G., Solís, N., Pizarro, M., Luigi Accatino, L., & Sáez, J. C. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00298.2001 · Cited by 88
Lin, W.-T., Huang, H.-L., Huang, M.-C., Chan, T.-F., Ciou, S.-Y., Lee, C.-Y., Chiu, Y.-W., Duh, T., Lin, P.-L., Wang, T.-N., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.121 · Cited by 86
Interaction between uric acid and HMGB1 translocation and release from endothelial cells
Rabadi, M. M., Kuo, M., Ghaly, T., Rabadi, S. M., Weber, M., Goligorsky, M. S., & Ratliff, B. B. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00520.2011 · Cited by 79
Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy
Wu, J., Chen, X., Xie, Y., Yamanaka, N., Shi, S., Wu, D., Liu, S., & Cai, G. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh716 · Cited by 75
Fairbanks, L. D. (2002) · QJM · doi:10.1093/qjmed/95.9.597 · Cited by 75
Serum Uric Acid Independently Predicts Cardiovascular Events in Advanced Nephropathy
Kanbay, M., Yılmaz, M. İ., Sönmez, A., Solak, Y., Sağlam, M., Çakır, E., Ünal, H. U., Arslan, E., Verim, S., Madero, M., et al. (2012) · American Journal of Nephrology · doi:10.1159/000342390 · Cited by 70
Self-citationAkalin, E., Ganeshan, S. V., Winston, J. A., & Muntner, P. (2008) · Transplantation · doi:10.1097/tp.0b013e3181814f5b · Cited by 66
Kamatani, N., Shin, F., Hada, T., Hosoya, T., Kohri, K., Toshitaka, N., Ueda, T., Tetsuya, Y., Hisashi, Y., & Yuji, M. (2011) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e31821d352f · Cited by 50
Combination of Captopril and Allopurinol Retards Fructose-Induced Metabolic Syndrome
Roncal, C. A., Reungjui, S., Sánchez‐Lozada, L. G., Mu, W., Sautin, Y. Y., Nakagawa, T., & Johnson, R. J. (2009) · American Journal of Nephrology · doi:10.1159/000235731 · Cited by 40
Self-citationSmink, P. A., Bakker, S. J. L., Laverman, G. D., Berl, T., Cooper, M. E., de Zeeuw, D., & Heerspink, H. J. L. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835200f9 · Cited by 38
Roncal, C., Mu, W., Reungjui, S., et al. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00216.2007 · Cited by 37
Ito, S., Naritomi, H., Ogihara, T., Shimada, K., Shimamoto, K., Tanaka, H., & Yoshiike, N. (2012) · Hypertension Research · doi:10.1038/hr.2012.59 · Cited by 35
Park, B., Park, E. A., Cho, S. J., Kim, Y., Lee, H., Min, J., Ha, E., Kang, D., & Park, H. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.12 · Cited by 27
Self-citationChildhood course of renal insufficiency in a family with a uromodulin gene mutation
Schäffer, P., Gombos, É., Meichelbeck, K., Kiss, A., Hart, P. S., & Bleyer, A. J. (2010) · Pediatric Nephrology · doi:10.1007/s00467-009-1436-y · Cited by 22
Lai, J. Y., Atzmon, G., Melamed, M. L., Hostetter, T. H., Crandall, J. P., Barzilai, N., & Bitzer, M. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03902.x · Cited by 9
Cited by
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
Levin, A., Tonelli, M., Bonventre, J., Coresh, J., Donner, J.-A., Fogo, A. B., Fox, C. S., Gansevoort, R. T., Heerspink, H. J. L., Jardine, M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30788-2 · Cited by 919
Mechanisms by Which Dehydration May Lead to Chronic Kidney Disease
Roncal-Jimenez, C., Lanaspa, M. A., Jensen, T., Sanchez-Lozada, L. G., & Johnson, R. J. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000381239 · Cited by 693
Self-citationJohnson, R. J., Bakris, G. L., Borghi, C., Chonchol, M. B., Feldman, D., Lanaspa, M. A., Merriman, T. R., Moe, O. W., Mount, D. B., Sanchez Lozada, L. G., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.12.009 · Cited by 644
Self-citationUric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review
Sharaf El Din, U. A. A., Salem, M. M., & Abdulazim, D. O. (2017) · Journal of Advanced Research · doi:10.1016/j.jare.2016.11.004 · Cited by 417
Mitochondrial dysfunction in the pathophysiology of renal diseases
Che, R., Yuan, Y., Huang, S., & Zhang, A. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00571.2013 · Cited by 394
Metadata
- Authors
- Johnson, R. J., Nakagawa, T., Jalal, D., Sanchez-Lozada, L. G., Kang, D.-H., & Ritz, E.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-03-29
- Volume
- 28
- Issue
- 9
- Pages
- 2221-2228
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2137951385
- Cited by
- 654
- References
- 69
- FWCI
- 25.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.